Murchinson Ltd. Vallon Pharmaceuticals, Inc. Transaction History

Murchinson Ltd.

  • $566 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.02 - $7.3 $301,238 - $547,025
-74,935 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.85 - $9.68 $461,865 - $1.16 Million
-119,965 Reduced 61.55%
74,935 $545,000
Q2 2021

Aug 13, 2021
BUY
$3.66 - $5.83 $713,334 - $1.14 Million
194,900 New
194,900 $1.06 Million

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Murchinson Ltd. Portfolio

Follow Murchinson Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Murchinson Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email